Overview
David Ashley is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Ashley is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri. Dr. Ashley is currently accepting new patients.
His clinical research consists of co-authoring 137 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Duke Cancer Center
My clinical practice if focused on the care of patients with breast cancer, particularly those diagnosed at a younger age and those with recurrence in the central nervous system. I am committed to the care of patients with breast cancer brain metastases, and I am honored to serve as the Medical Director of the Brain and Spine Metastases Program in the Duke Cancer Center. In this role, our multidisciplinary team provides well-coordinated care for patients with breast cancer and other solid tumor types that have metastasized to the central nervous system. In addition, I enjoy helping young women diagnosed with breast cancer navigate their treatment decisions to ensure both excellent medical care and attention to individual challenges, such as future fertility, sequelae of treatment on longer-term health, and impact on current and future relationships. When not working, I enjoy running, reading, and traveling with my family. Dr. Anders is rated as an Elite provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Breast Cancer, Brain Tumor, Triple-Negative Breast Cancer, and HER-2 Positive Breast Cancer.
Duke Cancer Center
I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.
James Vredenburgh is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Vredenburgh is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, Brain Tumor, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Ashley isElite. Learn about Astrocytoma.
- Brain TumorDr. Ashley isElite. Learn about Brain Tumor.
- GlioblastomaDr. Ashley isElite. Learn about Glioblastoma.
- GliomaDr. Ashley isElite. Learn about Glioma.
- Gliomatosis CerebriDr. Ashley isElite. Learn about Gliomatosis Cerebri.
- Distinguished
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Ashley isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Embryonal Tumor with Multilayered RosettesDr. Ashley isDistinguished. Learn about Embryonal Tumor with Multilayered Rosettes.
- GliosarcomaDr. Ashley isDistinguished. Learn about Gliosarcoma.
- NeuroepitheliomaDr. Ashley isDistinguished. Learn about Neuroepithelioma.
- OligodendrogliomaDr. Ashley isDistinguished. Learn about Oligodendroglioma.
- Advanced
- EpendymomaDr. Ashley isAdvanced. Learn about Ependymoma.
- GangliogliomaDr. Ashley isAdvanced. Learn about Ganglioglioma.
- MedulloblastomaDr. Ashley isAdvanced. Learn about Medulloblastoma.
- Metastatic Brain TumorDr. Ashley isAdvanced. Learn about Metastatic Brain Tumor.
- Pediatric Low-Grade Glioma (pLGG)Dr. Ashley isAdvanced. Learn about Pediatric Low-Grade Glioma (pLGG).
- Posterior Fossa TumorDr. Ashley isAdvanced. Learn about Posterior Fossa Tumor.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Ashley isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Soft Tissue SarcomaDr. Ashley isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Ataxia-TelangiectasiaDr. Ashley isExperienced. Learn about Ataxia-Telangiectasia.
- Brain Stem CancerDr. Ashley isExperienced. Learn about Brain Stem Cancer.
- Breast CancerDr. Ashley isExperienced. Learn about Breast Cancer.
- Diffuse Midline Glioma H3 K27M-MutantDr. Ashley isExperienced. Learn about Diffuse Midline Glioma H3 K27M-Mutant.

